Location History:
- Schleswig-Holstein, DE (2015)
- Wahlstedt, DE (2016)
Company Filing History:
Years Active: 2015-2016
Title: Uwe Mamat: Innovator in Gram-Negative Bacteria Research
Introduction
Uwe Mamat is a notable inventor based in Wahlstedt, Germany. He has made significant contributions to the field of microbiology, particularly in the development of viable gram-negative bacteria with reduced proteolytic activity. His work has implications for various applications in biotechnology and medicine.
Latest Patents
Uwe Mamat holds 2 patents that focus on innovative methods involving gram-negative bacteria. His latest patents include:
1. **Viable gram negative bacteria with reduced proteolytic activity lacking outer membrane agonists of TLR4/MD-2** - This patent describes gram-negative bacteria or components that lack ligands such as Lipid A or 6-acyl lipid polysaccharide, which act as agonists of TLR4/MD-2. The bacteria may exhibit reduced activity of arabinose-5-phosphate isomerases and may include suppressor mutations that enhance the transport capacity for lipid IVA.
2. **Viable gram negative bacteria lacking outer membrane agonists of TLR4/MD-2** - Similar to the first, this patent outlines gram-negative bacteria that lack specific ligands and may be competent to take up extracellular DNA. The invention also includes methods for creating and utilizing these bacteria.
Career Highlights
Uwe Mamat is associated with Research Corporation Technologies, Inc., where he continues to advance his research in microbiology. His innovative work has positioned him as a key figure in the development of new bacterial strains with potential applications in various fields.
Collaborations
Uwe collaborates with David Bramhill, contributing to the advancement of their shared research interests. Their partnership enhances the scope and impact of their work in the field.
Conclusion
Uwe Mamat's contributions to the field of microbiology through his patents and collaborations highlight his role as an innovator. His research on gram-negative bacteria has the potential to lead to significant advancements in biotechnology and medicine.